Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Nuvectis Pharma, Inc. (NVCT)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
15 Aug 2023
BENTSUR RON
Chairman & CEO, Director, Officer, 10% Owner
Nuvectis Pharma, Inc.
(NVCT)
3,232,544
+0%
350
$14.61
$5,112.15
BUY
8 Aug 2023
BENTSUR RON
Chairman & CEO, Director, Officer, 10% Owner
Nuvectis Pharma, Inc.
(NVCT)
3,232,194
+0%
300
$14.73
$4,418.40
BUY
31 Jul 2023
Mosseri Marlio Charles
10% Owner
Nuvectis Pharma, Inc.
(NVCT)
2,595,000
+0%
860
$13.88
$11,936.80
BUY
28 Jul 2023
Mosseri Marlio Charles
10% Owner
Nuvectis Pharma, Inc.
(NVCT)
2,594,140
+0%
2,584
$13.91
$35,943.44
BUY
27 Jul 2023
Mosseri Marlio Charles
10% Owner
Nuvectis Pharma, Inc.
(NVCT)
2,591,556
+0%
1,556
$13.98
$21,752.88
BUY
26 Jul 2023
Mosseri Marlio Charles
10% Owner
Nuvectis Pharma, Inc.
(NVCT)
2,590,000
+0%
10,000
$13.97
$139,700.00
BUY
18 Jul 2023
Mosseri Marlio Charles
10% Owner
Nuvectis Pharma, Inc.
(NVCT)
2,563,762
+0%
9,149
$14.84
$135,771.16
BUY
12 Jul 2023
Mosseri Marlio Charles
10% Owner
Nuvectis Pharma, Inc.
(NVCT)
2,554,613
+0%
3,285
$15.09
$49,570.65
BUY
11 Jul 2023
Mosseri Marlio Charles
10% Owner
Nuvectis Pharma, Inc.
(NVCT)
2,551,328
+0%
10,000
$15.36
$153,600.00
BUY
7 Jul 2023
Mosseri Marlio Charles
10% Owner
Nuvectis Pharma, Inc.
(NVCT)
2,541,328
+0%
8,948
$15.19
$135,920.11
BUY
7 Jul 2023
BENTSUR RON
Chairman & CEO, Director, Officer, 10% Owner
Nuvectis Pharma, Inc.
(NVCT)
3,231,359
+0%
260
$15.52
$4,035.40
BUY
6 Jul 2023
Mosseri Marlio Charles
10% Owner
Nuvectis Pharma, Inc.
(NVCT)
2,532,380
+0%
3,179
$15.01
$47,716.79
BUY
6 Jul 2023
BENTSUR RON
Chairman & CEO, Director, Officer, 10% Owner
Nuvectis Pharma, Inc.
(NVCT)
3,231,099
+0%
320
$14.88
$4,761.60
BUY
5 Jul 2023
Mosseri Marlio Charles
10% Owner
Nuvectis Pharma, Inc.
(NVCT)
2,529,201
+0%
1,176
$15.52
$18,251.52
BUY
26 Jun 2023
Mosseri Marlio Charles
10% Owner
Nuvectis Pharma, Inc.
(NVCT)
2,528,025
+0%
16,760
$16.46
$275,869.60
BUY
26 Jun 2023
BENTSUR RON
Chairman & CEO, Director, Officer, 10% Owner
Nuvectis Pharma, Inc.
(NVCT)
3,230,779
+0%
750
$16.50
$12,375.00
BUY
23 Jun 2023
Mosseri Marlio Charles
10% Owner
Nuvectis Pharma, Inc.
(NVCT)
2,511,265
+3%
73,175
$17.43
$1,275,440.20
BUY
21 Jun 2023
BENTSUR RON
Chairman & CEO, Director, Officer, 10% Owner
Nuvectis Pharma, Inc.
(NVCT)
3,230,029
+0%
500
$17.88
$8,940.00
BUY
21 Jun 2023
Mosseri Marlio Charles
10% Owner
Nuvectis Pharma, Inc.
(NVCT)
2,438,090
+0%
13,090
$17.72
$231,963.88
BUY
16 Jun 2023
Mosseri Marlio Charles
10% Owner
Nuvectis Pharma, Inc.
(NVCT)
2,425,000
+0%
12,700
$17.75
$225,425.00
BUY
15 Jun 2023
Mosseri Marlio Charles
10% Owner
Nuvectis Pharma, Inc.
(NVCT)
2,380,576
+1%
32,124
$17.71
$568,848.00
BUY
7 Jun 2023
BENTSUR RON
Chairman & CEO, Director, Officer, 10% Owner
Nuvectis Pharma, Inc.
(NVCT)
3,229,529
+0%
350
$17.45
$6,107.90
BUY
31 May 2023
BENTSUR RON
Chairman & CEO, Director, Officer, 10% Owner
Nuvectis Pharma, Inc.
(NVCT)
3,229,179
+0%
330
$17.28
$5,702.40
BUY
24 May 2023
BENTSUR RON
Chairman & CEO, Director, Officer, 10% Owner
Nuvectis Pharma, Inc.
(NVCT)
3,228,849
+0%
200
$17.49
$3,498.00
BUY
16 May 2023
BENTSUR RON
Chairman & CEO, Director, Officer, 10% Owner
Nuvectis Pharma, Inc.
(NVCT)
3,228,649
+0%
320
$17.03
$5,448.00
BUY
27 Mar 2023
Poradosu Enrique
Chief Science & Business Off, Officer
Nuvectis Pharma, Inc.
(NVCT)
1,373,819
+0%
500
$11.55
$5,775.00
BUY
23 Mar 2023
BENTSUR RON
Chairman & CEO, Director, Officer, 10% Owner
Nuvectis Pharma, Inc.
(NVCT)
3,228,329
+0%
230
$12.13
$2,789.90
BUY
21 Mar 2023
Shemesh Shay
Chief Dev. & Ops. Officer, Officer
Nuvectis Pharma, Inc.
(NVCT)
1,361,955
+0%
420
$11.99
$5,035.80
BUY
21 Mar 2023
BENTSUR RON
Chairman & CEO, Director, Officer, 10% Owner
Nuvectis Pharma, Inc.
(NVCT)
3,228,099
+0%
480
$12.08
$5,798.40
BUY
15 Mar 2023
Shemesh Shay
Chief Dev. & Ops. Officer, Officer
Nuvectis Pharma, Inc.
(NVCT)
1,361,535
+0%
670
$10.71
$7,175.70
BUY
14 Mar 2023
BENTSUR RON
Chairman & CEO, Director, Officer, 10% Owner
Nuvectis Pharma, Inc.
(NVCT)
3,227,619
+0%
2,160
$10.86
$23,464.80
BUY
21 Dec 2022
Shemesh Shay
Chief Dev. & Ops. Officer, Officer
Nuvectis Pharma, Inc.
(NVCT)
1,245,865
+0%
500
$7.65
$3,825.00
BUY
17 Nov 2022
BENTSUR RON
Chairman & CEO, Director, Officer, 10% Owner
Nuvectis Pharma, Inc.
(NVCT)
3,014,859
+0%
750
$7.23
$5,425.00
BUY
16 Nov 2022
Shemesh Shay
Chief Dev. & Ops. Officer, Officer
Nuvectis Pharma, Inc.
(NVCT)
1,245,365
+0%
300
$7.15
$2,145.00
BUY
10 Nov 2022
BENTSUR RON
Chairman & CEO, Director, Officer, 10% Owner
Nuvectis Pharma, Inc.
(NVCT)
3,014,109
+0%
1,000
$7.07
$7,070.00
BUY
28 Sep 2022
BENTSUR RON
Chairman & CEO, Director, Officer, 10% Owner
Nuvectis Pharma, Inc.
(NVCT)
3,013,109
+0%
1,000
$7.35
$7,345.00
BUY
23 Sep 2022
Shemesh Shay
Chief Dev. & Ops. Officer, Officer
Nuvectis Pharma, Inc.
(NVCT)
1,245,065
+0%
220
$7.87
$1,731.40
BUY
23 Sep 2022
BENTSUR RON
Chairman & CEO, Director, Officer, 10% Owner
Nuvectis Pharma, Inc.
(NVCT)
3,012,109
+0%
1,500
$7.85
$11,775.00
BUY
2 Sep 2022
Shemesh Shay
Chief Dev. & Ops. Officer, Officer
Nuvectis Pharma, Inc.
(NVCT)
1,244,845
+0%
404
$8.31
$3,357.24
BUY
1 Sep 2022
BENTSUR RON
Chairman & CEO, Director, Officer, 10% Owner
Nuvectis Pharma, Inc.
(NVCT)
3,010,609
+0%
1,700
$8.29
$14,099.00
BUY
31 Aug 2022
Shemesh Shay
Chief Dev. & Ops. Officer, Officer
Nuvectis Pharma, Inc.
(NVCT)
1,244,441
+0%
3,006
$8.07
$24,258.42
BUY
23 Aug 2022
BENTSUR RON
Chairman & CEO, Director, Officer, 10% Owner
Nuvectis Pharma, Inc.
(NVCT)
3,008,909
+0%
1,500
$9.05
$13,570.00
BUY
18 Aug 2022
BENTSUR RON
Chairman & CEO, Director, Officer, 10% Owner
Nuvectis Pharma, Inc.
(NVCT)
3,007,409
+0%
19,426
$8.69
$168,725.08
BUY
28 Jun 2022
BENTSUR RON
Chairman & CEO, Director, Officer, 10% Owner
Nuvectis Pharma, Inc.
(NVCT)
2,968,314
+0%
4,000
$11.64
$46,540.00
BUY
22 Jun 2022
BENTSUR RON
Chairman & CEO, Director, Officer, 10% Owner
Nuvectis Pharma, Inc.
(NVCT)
2,964,314
+0%
700
$12.09
$8,462.00
BUY
26 May 2022
BENTSUR RON
Chairman & CEO, Director, Officer, 10% Owner
Nuvectis Pharma, Inc.
(NVCT)
2,963,614
+0%
1,000
$15.82
$15,820.00
BUY
20 May 2022
Shemesh Shay
Chief Dev. & Ops. Officer, Officer
Nuvectis Pharma, Inc.
(NVCT)
1,241,435
+0%
300
$16.54
$4,962.00
BUY
19 May 2022
BENTSUR RON
Chairman & CEO, Director, Officer, 10% Owner
Nuvectis Pharma, Inc.
(NVCT)
2,962,614
+0%
1,200
$16.73
$20,070.00
BUY
17 May 2022
BENTSUR RON
Chairman & CEO, Director, Officer, 10% Owner
Nuvectis Pharma, Inc.
(NVCT)
2,960,414
+0%
2,010
$19.48
$39,155.30
BUY
16 May 2022
Shemesh Shay
Chief Dev. & Ops. Officer, Officer
Nuvectis Pharma, Inc.
(NVCT)
1,241,135
+0%
242
$19.44
$4,704.10
BUY
13 May 2022
BENTSUR RON
Chairman & CEO, Director, Officer, 10% Owner
Nuvectis Pharma, Inc.
(NVCT)
2,959,404
+0%
1,700
$18.82
$31,990.00
BUY
12 May 2022
Poradosu Enrique
Chief Science & Business Off, Officer
Nuvectis Pharma, Inc.
(NVCT)
1,258,019
+0%
670
$15.33
$10,273.20
BUY
12 May 2022
Hoberman Kenneth
Director
Nuvectis Pharma, Inc.
(NVCT)
55,140
+12%
6,000
$17.40
$104,400.00
BUY
12 May 2022
Kaplan Matthew L.
Director
Nuvectis Pharma, Inc.
(NVCT)
33,937
+9%
3,000
$16.88
$50,632.73
BUY
12 May 2022
Shemesh Shay
Chief Dev. & Ops. Officer, Officer
Nuvectis Pharma, Inc.
(NVCT)
1,239,651
+0%
1,278
$15.85
$20,254.66
BUY
12 May 2022
BENTSUR RON
Chairman & CEO, Director, Officer, 10% Owner
Nuvectis Pharma, Inc.
(NVCT)
2,946,559
+0%
12,245
$16.99
$208,046.70
BUY
28 Mar 2022
BENTSUR RON
Chairman & CEO, Director, Officer, 10% Owner
Nuvectis Pharma, Inc.
(NVCT)
2,825,459
+0%
4,000
$7.05
$28,200.00
BUY
17 Mar 2022
BENTSUR RON
Chairman & CEO, Director, Officer, 10% Owner
Nuvectis Pharma, Inc.
(NVCT)
2,821,459
+0%
7,000
$7.63
$53,410.00
BUY
14 Feb 2022
BENTSUR RON
Chairman & CEO, Director, Officer
Nuvectis Pharma, Inc.
(NVCT)
2,814,459
+0%
8,000
$5.88
$47,040.00
BUY
10 Feb 2022
BENTSUR RON
Chairman & CEO, Director, Officer
Nuvectis Pharma, Inc.
(NVCT)
2,806,459
+0%
8,500
$6.34
$53,890.00
BUY
4 Feb 2022
Poradosu Enrique
Chief Science & Business Off, Officer
Nuvectis Pharma, Inc.
(NVCT)
1,197,649
+0%
4,600
$3.44
$15,834.00
BUY
4 Feb 2022
Shemesh Shay
Chief Development Officer, Officer
Nuvectis Pharma, Inc.
(NVCT)
1,179,615
+0%
2,946
$3.41
$10,033.62
BUY
4 Feb 2022
BENTSUR RON
Chairman & CEO, Director, Officer
Nuvectis Pharma, Inc.
(NVCT)
2,791,959
+9%
232,500
$4.96
$1,153,145.00
Home